跳至主要内容
临床试验/ISRCTN90354265
ISRCTN90354265已完成Unknown

tility of botulinum toxin type A in the treatment of chronic anal fissure

Hospital General Nuestra Señora del Prado0 个研究点目标入组 49 人开始时间: 2024年2月16日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
49

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Aged over 18 years
  • 2. Clinical anal fissure diagnosis for over 2 months that had not responded to previous treatments consisting of dietary and behavioral modifications, analgesics, and local treatment with calcium channel blocker (diltiazem 2%) or nitrates (trinitrate glyceryl 0.4%)

排除标准

  • 1. Non-idiopathic anal fissures
  • 2. Previously untreated patients
  • 3. BT contraindication such as miastenia gravis, Eaton-Lambert syndrome, pregnancy, and acetylcholine deficiency

研究者

发起方
Hospital General Nuestra Señora del Prado

相似试验